Key Takeaways
- • 1789 Capital, the venture firm where Donald Trump Jr. serves as partner, invested $300 million into Polymarket at an August 2025 valuation, with Trump Jr. joining Polymarket's advisory board as part of the deal.
- • Polymarket's valuation surged to approximately $15 billion by spring 2026, representing a nearly 50x return on 1789 Capital's initial investment—one of the most profitable venture deals in recent memory.
- • 1789 Capital reported returns of roughly 200% as of June 30, 2026, significantly outpacing peer venture firms averaging 21% returns over the same period, with the firm's assets under management growing from several hundred million to over $3 billion.
- • Regulatory clearance from the Commodity Futures Trading Commission on November 25, 2025, granted Polymarket full licensing to operate as a regulated platform in the United States, a critical catalyst that preceded the valuation spike.
- • The timing of the investment, regulatory approval, and valuation explosion has drawn congressional scrutiny in August 2026, with lawmakers questioning the confluence of these events.
Summary
1789 Capital's $300 million equity investment in Polymarket, announced on August 26, 2025, has emerged as one of the highest-returning venture capital deals in recent history. The investment valued Polymarket at approximately $300 million at entry, with Donald Trump Jr.—a partner at 1789 Capital—joining Polymarket's advisory board as a condition of the deal. By spring 2026, Polymarket's valuation had escalated to an estimated $15 billion, delivering approximately 50x returns on the initial capital deployed.
The financial performance has been exceptional relative to venture market benchmarks. 1789 Capital reported fund-level returns of roughly 200% as of June 30, 2026, substantially exceeding the approximately 21% average return posted by peer venture firms during the identical period. The firm's assets under management expanded dramatically from several hundred million dollars prior to the 2024 election cycle to over $3 billion, reflecting both strong performance and capital inflows.
A critical inflection point occurred on November 25, 2025, when the Commodity Futures Trading Commission granted Polymarket comprehensive regulatory clearance to operate as a fully regulated platform within the United States. Prior to this approval, Polymarket had occupied regulatory ambiguity in the U.S. market, technically restricting domestic user participation. The CFTC license represented a transformative catalyst that unlocked institutional capital access and market expansion, directly preceding the valuation surge to $15 billion.
The temporal clustering of events—1789 Capital's August 2025 investment entry, the November 2025 CFTC regulatory approval, and the subsequent valuation explosion to $15 billion by spring 2026—has triggered congressional scrutiny. Lawmakers have begun requesting explanations regarding the timing and circumstances surrounding these developments, with particular focus on whether material information regarding regulatory outcomes may have informed investment decisions.
The financial performance has been exceptional relative to venture market benchmarks. 1789 Capital reported fund-level returns of roughly 200% as of June 30, 2026, substantially exceeding the approximately 21% average return posted by peer venture firms during the identical period. The firm's assets under management expanded dramatically from several hundred million dollars prior to the 2024 election cycle to over $3 billion, reflecting both strong performance and capital inflows.
A critical inflection point occurred on November 25, 2025, when the Commodity Futures Trading Commission granted Polymarket comprehensive regulatory clearance to operate as a fully regulated platform within the United States. Prior to this approval, Polymarket had occupied regulatory ambiguity in the U.S. market, technically restricting domestic user participation. The CFTC license represented a transformative catalyst that unlocked institutional capital access and market expansion, directly preceding the valuation surge to $15 billion.
The temporal clustering of events—1789 Capital's August 2025 investment entry, the November 2025 CFTC regulatory approval, and the subsequent valuation explosion to $15 billion by spring 2026—has triggered congressional scrutiny. Lawmakers have begun requesting explanations regarding the timing and circumstances surrounding these developments, with particular focus on whether material information regarding regulatory outcomes may have informed investment decisions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.